Role of emerging new technologies

Diabetes Technology and Therapeutics

Volumn 10, Issue 5, 2008, Pages 413-414

  Garg, Satish K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

BLOOD GLUCOSE MONITORING; DEVICE; DIABETES MELLITUS; EDITORIAL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN PUMP; MEDICAL TECHNOLOGY; PATIENT EDUCATION; PRIORITY JOURNAL; SELF MONITORING;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; TREATMENT OUTCOME;

EID: 50049136006     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0069     Document Type: Editorial

References (12)

1. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-853.
3. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649.
4. Tierney MJ, Tamada JA, Potts RO, Jovanovic L, Garg S; Cygnus Research Team: Clinical evaluation of the GlucoWatch® Biographer: a continual non-invasive glucose monitor for patients with diabetes. Biosensors Bioelectronics 2001;16:621-629.
5. Garg SK, Hoff HK, Chase HP: The role of continuous glucose sensors in diabetes care. Endocrinol Metab Clin North Am 2004;33:163-173.
6. Chase HP, Roberts MD, Wightman C, Klingensmith G, Garg SK, Van Wyhe M, Desai S, Harper W, Lopatin M, Bartkowiak M, Tamada J, Eastman RC: Use of the GlucoWatch Biographer in children with type 1 diabetes. Pediatrics 2003;111:790-794.
7. Ellis SL, Bookout T, Izuora K, Garg S: Use of continuous glucose monitoring to improve diabetes mellitus management. Endocrinol Metab Clinics North Am 2007;(Suppl 2):1-23.
8. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27:734-738.
9. Bailey TS, Zisser HC, Garg SK: Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 2007;9:203-210.
10. Deiss D, Bolinder J, Riveline J, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732.
11. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA: Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008;10:377-383.
12. Chase HP: Understanding Insulin Pumps and Continuous Glucose Monitors. Denver: Children's Diabetes Foundation Denver, 2007. Available by calling 1-800-695-2873.